I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now - The Motley Fool
I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now The Motley Fool
I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now The Motley Fool
Johnson & Johnson recalls Automated Impella Controllers after 3 patient deaths MassDevice
US FDA expands approval for J&J's drug for rare blood disorder Reuters
Family Receives Judgment Against J&J, Others Mesothelioma Guide
Johnson & Johnson scores 1st FDA label expansion for Imaavy Fierce Pharma
Johnson & Johnson vs. Thermo Fisher: Which Healthcare Growth Story Is More Durable? Yahoo Finance
Johnson & Johnson’s Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September Johnson & Johnson
How Much Upside Is Left in JNJ Stock? Trefis
Johnson & Johnson Is Near a Record High. Is There Still Room to Run? 24/7 Wall St.
Governor Shapiro Secures Over $1 Billion Investment from Johnson & Johnson to Build New Cancer-Fighting Manufacturing Facility in Montgomery County, Creating More Than 500 New Jobs PA Department of Community & Economic Development (.gov)
Top Analyst Reports for JPMorgan, Johnson & Johnson & Mastercard Zacks Investment Research
Johnson & Johnson (JNJ) Wins FDA Approval For First Warm Autoimmune Hemolytic Anemia Treatment simplywall.st
I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now The Motley Fool
Is Johnson & Johnson’s $5.5 Billion Talc Settlement a Buy Signal, or Is the Legal Risk Far From Over? Yahoo Finance
Johnson & Johnson names new vice president for litigation Reuters
Johnson & Johnson (JNJ) Expands Tecvayli Approval In Europe For Multiple Myeloma simplywall.st
Johnson & Johnson Just Got a Big FDA Win The Motley Fool
China approves J&J's oral psoriasis pill, says drugmaker Yahoo Finance
Johnson & Johnson Just Sent Shareholders an Important 11-Word Message About Its Future Yahoo Finance
Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson? The Motley Fool
Johnson and Johnson Earnings Report | 2026 Q2 Infographic Johnson & Johnson
Johnson & Johnson’s Dividend Looks Well Positioned for the Long Term Yahoo Finance
Johnson & Johnson makes WSJ 2026 Best Companies for the Future list Johnson & Johnson
Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System Johnson & Johnson
J&J Stock: Analysis, Forecast & Dividend 2026 Steady
Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida Johnson & Johnson
Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania Johnson & Johnson
J&J quarterly earnings beat Wall Street estimates on strength of medicines unit CNBC
Johnson & Johnson embarks on supply chain restructuring Supply Chain Dive
Johnson & Johnson offers $5.5 billion to settle talc lawsuits CBS News
J&J innovative medicine chief Jennifer Taubert to retire, handing reins to North America head Fierce Pharma
Johnson & Johnson offers up to $5.5bn to settle baby powder lawsuits BBC
J&J lowers 2026 profit forecast on deal costs, sees further hit in 2027 Reuters
Is Johnson & Johnson (NYSE:JNJ) drawing defensive demand as the rate debate heats up? Kalkine Media
Johnson & Johnson offers $5.5bn to settle talc cancer lawsuits Al Jazeera
Johnson & Johnson (JNJ) Stock Looks Cheap On Cash Flow But Rich On Earnings Yahoo Finance
Missouri woman sues Johnson & Johnson, claims baby powder caused ovarian cancer KCTV
Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit The Guardian
Johnson & Johnson stock holds above $270 as FDA win and guidance lift support the rally Ad-hoc-news.de
Johnson & Johnson Names Tom Cavanaugh to Lead Innovative Medicine Business citybiz